aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2021 Financial Results

Rhea-AI Summary

aTyr Pharma (Nasdaq: LIFE) announced it will release its Q4 and full year 2021 financial results on March 14, 2022, after the market close. The management will host a conference call and webcast at 5:00 PM EDT to discuss the results and provide a corporate update. aTyr focuses on discovering and developing innovative medicines from novel biological pathways, particularly through its product candidate efzofitimod, targeting inflammatory lung diseases.

Management to host conference call and webcast on March 14th at 5:00 pm EDT / 2:00 pm PDT

SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that it will report fourth quarter and full year 2021 financial results and provide a corporate update after the market close on Monday, March 14, 2022. Management will host a conference call and webcast to review the results and provide an operational update.

Conference Call and Webcast Details:
Monday, March 14th @ 5:00 p.m. EDT / 2:00 p.m. PDT
Domestic: 844-358-9116
International: 209-905-5951
Conference ID: 3686825
Webcast: http://investors.atyrpharma.com/events-and-webcasts

About aTyr

aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to downregulate immune engagement in inflammatory lung diseases. For more information, please visit http://www.atyrpharma.com.

Contact:
Ashlee Dunston
Director, Investor Relations and Corporate Communications
adunston@atyrpharma.com

FAQ

When will aTyr Pharma report its fourth quarter financial results for 2021?

aTyr Pharma will report its fourth quarter financial results on March 14, 2022, after market close.

What time is the aTyr Pharma conference call on March 14, 2022?

The aTyr Pharma conference call is scheduled for 5:00 PM EDT on March 14, 2022.

What is efzofitimod in relation to aTyr Pharma?

Efzofitimod is a clinical-stage product candidate developed by aTyr Pharma, targeting inflammatory lung diseases.

How can I access the webcast for aTyr Pharma's conference call?

The webcast for aTyr Pharma's conference call can be accessed at their investor relations website.